findmyKOL
Clinical trialNCT00458796TerminatedInterventional

Comparison of Two Schedules of Zoledronic Acid in Treating Patients With Breast Cancer That Has Spread to the Bone

SponsorUniversity of LeedsEnrollment1,500Breast CancerHypercalcemia of MalignancyMetastatic CancerMusculoskeletal ComplicationsPain
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

30 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United Kingdom
  • Royal Bournemouth Hospital

    Bournemouth, England, United Kingdom

  • Derbyshire Royal Infirmary

    Derby, England, United Kingdom

  • Doncaster Royal Infirmary

    Doncaster, England, United Kingdom

  • University Hospital of North Durham

    Durham, England, United Kingdom

  • Diana Princess of Wales Hospital

    Grimsby, England, United Kingdom

  • St. Luke'S Cancer Centre at Royal Surrey County Hospital

    Guildford, England, United Kingdom

  • Huddersfield Royal Infirmary

    Huddersfield, West Yorks, England, United Kingdom

  • Royal Liverpool University Hospital

    Liverpool, England, United Kingdom

  • Saint Bartholomew'S Hospital

    London, England, United Kingdom

  • Christie Hospital

    Manchester, England, United Kingdom

  • Withington Hospital

    Manchester, England, United Kingdom

  • Clatterbridge Centre for Oncology

    Merseyside, England, United Kingdom

  • George Eliot Hospital

    Nuneaton, England, United Kingdom

  • Dorset Cancer Centre

    Poole Dorset, England, United Kingdom

  • Scunthorpe General Hospital

    Scunthorpe, England, United Kingdom

  • Cancer Research Centre at Weston Park Hospital

    Sheffield, England, United Kingdom

  • Royal Shrewsbury Hospital

    Shrewsbury, England, United Kingdom

  • Solihull Hospital

    Solihull, England, United Kingdom

  • Southampton General Hospital

    Southampton, England, United Kingdom

  • South Warwickshire Hospital

    Warwick, Warwickshire, England, United Kingdom

  • Southend University Hospital Nhs Foundation Trust

    Westcliff-on-Sea, England, United Kingdom

  • Royal Hampshire County Hospital

    Winchester, England, United Kingdom

  • Beatson West of Scotland Cancer Centre

    Glasgow, Scotland, United Kingdom

  • Hairmyres Hospital

    Glasgow, Scotland, United Kingdom

  • Western Infirmary

    Glasgow, Scotland, United Kingdom

  • Crosshouse Hospital

    Kilmarnock, Scotland, United Kingdom

  • Velindre Cancer Center at Velindre Hospital

    Cardiff, Wales, United Kingdom

  • Withybush General Hospital

    Haverfordwest, Wales, United Kingdom

  • Royal Gwent Hospital

    Newport Gwent, Wales, United Kingdom

  • South West Wales Cancer Institute

    Swansea, Wales, United Kingdom

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Mar 2006
Primary completion
Completion
Last update posted
27 May 2022
Registered enrollment
1,500
Registry id
NCT00458796

Cross-registrations

ISRCTN (UK)ISRCTN83586728

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.